Nanite

Non-viral gene delivery.

Edited:

📋 Overview of Nanite

Founding Year

2021

Estimated Funding

$0000

Size

$0000

Locations

Boston

Primary Industry

Biotechnology, Industry

📙 About Nanite

Nanite offers genetic drug delivery with AI-driven polymer design and multiplexed in vivo screening to develop nanoparticles for tissue-specific delivery. Their innovative platform, SAYER, integrates high-throughput synthesis, biology, materials science, and AI to create safe and resorbable polymer nanoparticles (PNPs). These PNPs offer advantages over traditional viral vectors and lipid nanoparticles, providing a safer and more efficient method for gene therapy.

💰 Recent Investors of Nanite

Arkitekt Ventures, Cystic Fibrosis Foundation, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.